Cognitive-behavioral therapy augmentation of SSRI reduces cortisol levels in older adults with generalized anxiety disorder: A randomized clinical trial.
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: Elevated cortisol in stress and aging, such as has been seen in late-life anxiety disorders, is postulated to accelerate cognitive and physiological decline in this large and increasing population. Selective serotonin-reuptake inhibitors (SSRIs) and cognitive-behavioral therapy (CBT) are both effective treatments for generalized anxiety disorder (GAD) in older adults. On the other hand, there is very little research examining the effect of combining these therapies on peak cortisol levels. For the current analyses, we examined the effectiveness of CBT augmentation on peak cortisol levels in older adults diagnosed with GAD. METHODS: The sample consisted of 42 individuals with late-life GAD who received an acute course of the SSRI escitalopram and then entered a 16-week randomized phase. Twenty-one participants were randomized to receive 16 sessions of CBT in addition to continuing escitalopram and the remaining 21 participants continued on escitalopram without CBT. Generalized estimating equations were performed to assess the effectiveness of CBT augmentation on peak cortisol levels (30 min after waking). RESULTS: Older adults with GAD who received both escitalopram and CBT demonstrated a significant reduction in peak cortisol levels at posttreatment compared to the group who received escitalopram without CBT augmentation. CONCLUSIONS: CBT augmentation of SSRI treatment reduced peak cortisol levels for older adults with GAD. Since persistently high cortisol levels in aging are thought to increase age-related cognitive and medical problems, our findings suggest that there may be a benefit to health and cognition of CBT augmentation for late-life anxiety disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Miller, M. D., Paradis, C. F., Houck, P. R., Mazumdar, S., Stack, J. A., Rifai, A. H., Mulsant, B., & Reynolds, C. F. (1992) · Psychiatry Research · doi:10.1016/0165-1781(92)90005-n · Cited by 1,990 · cited 1×
“Background Characteristics and Pre-Augmentation Measures At the beginning of the study, participants were assessed for medical burden using the Cumulative Illness Rating Scale for Geriatrics (CIRS-G: Miller et al., 1992) as an index of medical comorbidity.”
MethodPruessner, J. C., Wolf, O. T., Hellhammer, D. H., Buske-Kirschbaum, A., von Auer, K., Jobst, S., Kaspers, F., & Kirschbaum, C. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)01008-4 · Cited by 1,450
Anxiety disorders in older adults: a comprehensive review
Wolitzky-Taylor, K. B., Castriotta, N., Lenze, E. J., Stanley, M. A., & Craske, M. G. (2010) · Depression and Anxiety · doi:10.1002/da.20653 · Cited by 726
Self-citationCampbell, J., & Ehlert, U. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.12.010 · Cited by 683
Determinants of the diurnal course of salivary alpha-amylase
Nater, U. M., Rohleder, N., Schlotz, W., Ehlert, U., & Kirschbaum, C. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.02.007 · Cited by 631
Gum, A. M., King-Kallimanis, B., & Kohn, R. (2009) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181ad4f5a · Cited by 357
Gould, R. L., Coulson, M. C., & Howard, R. J. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03824.x · Cited by 267
Porensky, E. K., Dew, M. A., Karp, J. F., Skidmore, E., Rollman, B. L., Shear, M. K., & Lenze, E. J. (2009) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31819b87b2 · Cited by 255 · cited 1×
“…(Ansseau et al, 2005; Romera et al., 2010), lower levels of health related quality of life (Wetherell et al., 2004), greater healthcare utilization (Porensky et al., 2009) and poorer cognitive performance (Butters et al., 2011; Mantella et al., 2007; Rosnick, Rawson, Butters, & Lenze, 2013) which…”
BackgroundSelf-citationStanley, M. A., Wilson, N. L., Novy, D. M., Rhoades, H. M., Wagener, P. D., Greisinger, A. J., Cully, J. A., & Kunik, M. E. (2009) · JAMA · doi:10.1001/jama.2009.458 · Cited by 247 · cited 2×
“…that cognitive behavioral therapy (CBT) reduces levels of worry, anxiety, depressive symptoms (Gould, Coulson, & Howard, 2012; Stanley et al., 2003; Stanley et al., 2009) and increases self-reported quality of life in older adults with GAD relative to waiting list (Ayers, Sorrell, Thorp, &…”
Background
Cited by
Fedotova, J., Kubatka, P., Büsselberg, D., Shleikin, A. G., Caprnda, M., Dragasek, J., Rodrigo, L., Pohanka, M., Gasparova, I., Nosal, V., et al. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.08.107 · Cited by 59
Cortisol and alpha-amylase assessment in psychotherapeutic intervention studies: A systematic review
Laufer, S., Engel, S., Knaevelsrud, C., & Schumacher, S. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.09.023 · Cited by 34
“Ryan et al. (2016) reviewed the literature regarding psychosocial intervention effects on salivary cortisol for a variety of mental and somatic disorders.”
Lelli, L., Castellini, G., Cassioli, E., Monteleone, A. M., & Ricca, V. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.03.046 · Cited by 30
Metadata
- Authors
- Rosnick, C. B., Wetherell, J. L., White, K. S., Andreescu, C., Dixon, D., & Lenze, E. J.
- Venue
- Journal of Consulting and Clinical Psychology
- Published
- 2016-04
- Volume
- 84
- Issue
- 4
- Pages
- 345-352
- ISSN
- 0022-006X (ISSN-L)
- 1939-2117
- OpenAlex
- W2278006365
- Cited by
- 43
- References
- 27
- FWCI
- 7.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cognitive-behavioral therapy augmentation of SSRI reduces cortisol levels in older adults with generalized anxiety disorder: A randomized clinical trial. https://app.cochat.ai/papers/10.1037/a0040113
- The paper
- Rosnick, C. B., Wetherell, J. L., White, K. S., Andreescu, C., Dixon, D., & Lenze, E. J. (2016). Cognitive-behavioral therapy augmentation of SSRI reduces cortisol levels in older adults with generalized anxiety disorder: A randomized clinical trial. Journal of Consulting and Clinical Psychology. https://doi.org/10.1037/a0040113
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.